Nestlé Health Science

1. Executive Summary (Confidence: High)

Nestlé Health Science (NHSc) has transitioned into a primary growth engine for the broader Nestlé Group, specifically targeting the expanding longevity and healthy aging sectors. A major strategic restructuring announced in early 2026 formalizes the integration of NHSc with Nestlé's global nutrition business, creating a unified powerhouse designed to capture operational synergies and research breakthroughs. Financially, the "Nutrition and Health Science" segment represents approximately CHF 13.1 billion in annual sales, with a clear focus on "billionaire brands" that provide high-margin, clinically-validated solutions. The company’s strategic shift emphasizes "Real Internal Growth" (RIG) through bio-innovation, particularly in cellular health (NAD+ precursors), metabolic management (Epitomee weight loss capsules), and gastrointestinal integrity. By positioning itself as a leader in "Medical Nutrition" and "Pharmaceutical Therapies," NHSc aims to bridge the gap between traditional dietary supplements and medical treatment, addressing the needs of aging populations globally.